Friday, November 13, 2026
Form 8-K tells shareholders about important events such as deals, leadership changes or results.
IRulya Therapeutics Posts Q3 2026 Results
The company released its quarterly financial figures for the period ending in 2026's third quarter, along with an update on its business. No specific numbers were given in the headline.
IRulya Therapeutics posts smaller quarterly loss than expected
The company reported a third-quarter loss of $2.31 per share, which was narrower than the $19.83 per share loss that had been anticipated.
Frequently asked questions
What is the latest news on IRLA?
Nov 13, 2026: IRulya Therapeutics Inc. filed a report on a major company event (Form 8-K) (SEC) · Nov 13, 2026: IRulya Therapeutics Posts Q3 2026 Results (Fiscal.ai) · Nov 13, 2026: IRulya Therapeutics posts smaller quarterly loss than expected (Benzinga)
What has IRLA filed with the SEC recently?
Nov 13, 2026: IRulya Therapeutics Inc. filed a report on a major company event (Form 8-K)
Get IRLA news as it happens
Every headline, SEC filing and analyst action for IRLA on your live chart, with important news marked and alerts when it matters.
Try SEPT Free